Open Access

Influence of Corynebacterium pseudotuberculosis infection on level of acute phase proteins in goats

  • Z. K. H. Jeber1,
  • Z. MohdJin1,
  • F. F. Jesse1Email author,
  • A. A. Saharee1,
  • J. Sabri2,
  • R. Yusoff1 and
  • H. Wahid1
Contributed equally
BMC Veterinary ResearchBMC series – open, inclusive and trusted201612:48

https://doi.org/10.1186/s12917-016-0675-y

Received: 30 September 2014

Accepted: 4 March 2016

Published: 9 March 2016

Abstract

Background

Goat caseous lymphadenitis (CLA) is a chronic disease caused by Corynebacterium pseudotuberculosis. However, there is paucity of data about goat’s acute phase response during the course of CLA. This study was conducted to investigate the response of acute phase proteins, mainly haptoglobin (Hp), serum amyloid A (SAA) and the negative acute phase response, especially albumin after an experimental challenge of C. pseudotuberculosis and phospholipase D (PLD) in Cross bred Boer goats.

Results

Serum Hp concentration in goats challenged with C. pseudotuberculosis (inoculated with 1x109 cfu subcutaneously) showed a significant increase, 5 fold in males (0.98 ± 0.12 mg/ml) and 3 fold in females (0.66 ± 0.12 mg/ml) compared to the control (0.2 ± 0.02 mg/ml). Challenge with PLD (1 ml/20 kg body weight intravenously) also showed significant increase, 4 fold in males and females (0.89 ± 0.11 mg/ml; 0.82 ± 0.12 mg/ml) respectively compared to the control (0.2 ± 0.02 mg/ml). Albumin concentration showed a significant decrease in both treated groups compared to the control. There were no significant changes in SAA concentration between challenged and control goats.

Conclusions

There was a significant response by Hp to C. pseudotuberculosis infection and PLD challenge. This was supported by the early acute response in which Hp was detected before CLA lesions were developed. Therefore, it concluded that C. pseudotuberculosis and PLD can influence the level of acute phase proteins in goats.

Keywords

Caseous lymphadenitis Corynebacterium pseudotuberculosis Phospholipase D Goat Acute phase response Haptoglobin Serum amyloid A

Background

Caseous lymphadenitis in goats distributed throughout almost the whole world. Goat CLA is found in all continents, Asia, Australia, Africa, Europe and Americas. Farmers suffer from heavy economic losses after affected carcasses are condemned at meat inspection in abattoirs as well as due to infection or death on farms [1, 2].

Caseous lymphadenitis has a long incubation period ranging between 25 and 140 days. The disease has distinct clinical manifestations when the lesions become progressive. Most common manifestations are abscesses in the superficial lymph nodes of the body and less often internally, infecting deeply laying lymph nodes and visceral organs especially mediastinal lymph nodes and the lungs [36]. C. pseudotuberculosis has a potent exotoxin, phospholipase D which is a key virulence factor in the development of CLA [7]. Carne [8] was the first to describe PLD from C. pseudotuberculosis. Since then it has been detected in every isolate of C. pseudotuberculosis studied, including both biotypes I and II from almost all mammalian species [9]. Earlier studies [5, 10, 11] suggested that at the initial stage of CLA, C. pseudotuberculosis parasitises macrophages and multiplies within them [3]. Phospholipase D plays a key role in infection by enabling the organism to escape the hydrolysis process within the macrophages, exerting its effect on the inner phospholipid layer of the macrophage’s cell membrane [12].

Acute phase proteins (APPs) are found in the blood and their concentration increases or decreases in response to infection, inflammation and injury. There are two types of APPs: positive APPs when their levels increase and negative APPs if their levels decrease [13]. Positive APPs increases in response to challenge and they include haptoglobin (Hp), C-reactive protein (CRP), serum amyloid A (SAA), ceruloplasmin (CP), alph 1-acid glycoprotein (AGP) and fibrinogen; while negative APPs are albumin and transferrin. Both types are synthesized by the liver upon pro-inflammatory cytokines stimulation and released directly into blood [14].

Generally, APPs contribute to body initiating the immune system in order to limit or overcome microbial growth. Acute phase proteins are considered sensitive biomarkers, but lack specificity for different infectious agents. They can also be used in diagnosis of inflammation, monitoring treatment progress, prognosis and health status screening [15]. APPs serum concentrations change in response to major pro-inflammatory cytokines such as interleukin-6 (IL-6), tumor necrosis factor (TNF) and interleukin 1-beta (IL-1-beta) [16]. These cytokines are released by various cells with immune function, such as keratinocytes, kupffer cells, mucosal epithelia and the pituitary gland, but particularly by macrophages in response to internal or external stimuli [17]. Haptoglobin, one of the alpha-globulin constituents binds to free haemoglobin (Hb), to inhibit Hb oxidative activity [18, 19]. It has several immune-modulatory functions, mediated via binding of Hp to the CD11-CD18 receptors [20, 21]. Haptoglobin has a bacteriocidal effect and it can also inhibit mast cell proliferation, stop the maturation of epidermal Langerhans cells and suppress T cell proliferation [2224]. Serum amyloid A is an apolipoprotein, a high density lipoprotein [25]. It has several functions such as detoxification of endotoxins, inhibition of endothelial and lymphocyte proliferation, blood platelet aggregation and it prevents T lymphocyte adherence to extracellular matrix proteins [26]. Serum amyloid A recruits the immune cells to the site of the infection and it may play a key role in inhibiting myeloperoxidase release during phagocyte migration, down-regulating the inflammatory process [27]. It is hypothesised that PLD challenge will stimulate APPs response in goat using the same pattern like from C. pseudotuberculosis infection. Thus, the aim of this study was to investigate and compare the influence of C. pseudotuberculosis infection and PLD challenge on the level of Hp and SAA in goats.

Methods

Ethics statement

The experiment was conducted according to the guidelines and approval of the Institutional Animal Care and Use Committee (IACUC) of Universiti Putra Malaysia, UPM (UPM/FPV/PS/3.2.1.551/AUP-R119).

Isolation and identification of C. pseudotuberculosis

C. pseudotuberculosis was isolated from clinical cases of caseous lymphadenitis in goats. Isolates were sent to the Veterinary Laboratory Service Unit (VLSU), Department of Veterinary Pathology and Microbiology, Faculty of Veterinary Medicine, Universiti Putra Malaysia for identification and confirmation of the bacteria according to principles and methods described in the microbiological diagnostic laboratory at the Veterinary Medical Teaching Hospital, University of California, Davis, Revised Edition 2008.

Extraction of phospholipase D

Phospholipase D, was extracted following the method described by Zaki [28]. Briefly, 2 or 3 loops of a 48 h culture of C. pseudotuberculosis were inoculated in a flask of freshly prepared bovine heart-liver medium. The flask was incubated anaerobically for 7 days at 37 °C in slanting position of 15° to 20°. The culture that developed a pellicle was used. Phospholipase D separation started with centrifugation of the culture medium at 8000 rpm/15 min in refrigerated centrifuge. The supernatant was collected and passed via sterile cellulose membrane filter (0.2 μm) and stored at 4Co then used in the experiment. The centrifugation sediment was checked for its purity by sub-culturing it on several blood agar plates and the supernatant (PLD) was checked for sterility by incubating a bottle of 50 ml at 37Co for 5 days. Then PLD was tittered for its potency using double dilution technique, washed bovine red blood cells and β-lysine from Staphylococcus aureus.

Experimental inoculations

Twenty six cross bred Boer goats (13 bucks and 13 does) aged between 12 and 14 months with no history of vaccination against CLA were screened twice (3 months apart) for CLA using agar gel immunodiffusion test (AGID) prior to the experiment. The goats were divided randomly into 3 groups; the 1st group consisted of 6 goats (3 males and 3 females) housed separately (to avoid mating and pregnancy hormonal changes) and inoculated with 1 ml PBS subcutaneously as control. The 2nd group consisted of 10 goats (5 males and 5 females housed separately) was inoculated with C. pseudotuberculosis 1x109 cfu subcutaneously; the 3rd group also consisted of 10 goats (5 males and 5 females housed separately) injected with PLD 1 ml/20 kg body weight intravenously [29].

Blood collection and analysis

Serial blood collections were done at 1 h, 3 h, 5 h, 8 h, 12 h then every 24 h post inoculation for 30 days during which the animals’ heath was monitored. Serum amyloid A concentration was measured using an ELISA kit (multi-species solid phase sandwich ELISA assay). Haptoglobin serum concentration was measured using an ELISA kit (multi-species colorimetric quantitative assay) with Hp control precision kit (Catalogue No: TP801-Con), all from Tridelta Development Ltd (Ireland). An ELISA reader machine from (BioRad) to read the optic density (OD) of both acute phase reactants.

Statistical analysis

Data were analyzed using SPSS version 19.0. One way analysis of variance (ANOVA) was used with Duncan post hoc multiple comparisons. All values were reported as mean ± SE at P < 0.05.

Results

Haptoglobin

Mean serum concentrations of haptoglobin showed significant increase (p < 0.05) in both C. pseudotuberculosis and phospholipase D inoculated groups compared with the unchallenged goats. The mean concentration of Hp was also significantly higher (p < 0.05) in the males than the females. However, mean serum concentration of Hp in C. pseudotuberculosis inoculated males was higher than phospholipase D inoculated males; while it was the opposite in the females where mean serum concentration of Hp was significantly higher (p < 0.05) in phospholipase D inoculated females than C. pseudotuberculosis inoculated females (Table 1).
Table 1

Mean serum haptoglobin concentration (combination of all results) of the goats post inoculation with C. pseudotuberculosis and PLD; n = 26 (Mean ± SE)

Groups

Control

C.pseudotuberculosis

Phospholipase D

Male

0.2 ± 0.02

*0.98 ± 0.12

*0.89 ± 0.11

Female

0.2 ± 0.02

*0.66 ± 0.12

*0.82 ± 0.12

*Significant value p < 0.05, comparison between inoculated groups and the control

Serum amyloid A

Mean serum concentration of amyloid A exhibits no significant changes (p > 0.05) in both treated groups compared with the control. Nevertheless, the females in C. pseudotuberculosis inoculated group showed higher mean serum concentration of SAA relatively to the males and to the unchallenged goats (Table 2).
Table 2

Mean serum amyloid A concentration (combination of all results) of the goats post inoculation with C. pseudotuberculosis and PLD; n = 26 (Mean ± SE)

Groups

Control

C.pseudotuberculosis

Phospholipase D

Male

148.33 ± 14.43

124.75 ± 13.06

156.25 ± 9.40

Female

145 ± 25.82

165 ± 10.32

156.25 ± 9.40

*Significant value p < 0.05, comparison between inoculated groups and the control

Albumin

The mean concentration of serum albumin showed significant decrease (p < 0.05) in week 1 to 3 post inoculation with C. pseudotuberculosis and PLD compared to the control then returned to its normal concentration on week 4 (Table 3).
Table 3

Albumin means concentration (combination of all results) of the goats post inoculation with C. pseudotuberculosis and PLD; n = 26 (Mean ± SE)

Groups

Control

C.pseudotuberculosis

Phospholipase D

Weeks

1

34.86 ± 1.04

*21.00 ± 5.75

*29.82 ± 1.17

2

35.56 ± 1.69

*21.44 ± 6.06

*27.78 ± 2.11

3

30.23 ± 2.33

*24.24 ± 6.26

*26.28 ± 1.98

4

31.76 ± 1.82

29.80 ± 3.16

31.88 ± 1.42

*Significant value p < 0.05. Comparison between inoculated groups and the control

Discussion

The gold standards of CLA diagnosis is the detection of the infected animals and preventing them from disseminating the disease or infecting the uninfected animals. The classical way of CLA diagnosis is via bacterial culture and identification of the microorganism. However, this is possible only when the disease has become chronic and the clinical signs appeared as abscesses in the superficial lymph nodes [7, 30].

Acute phase proteins are part of the innate immune defense mechanism which responds primarily to any kind of infection and expressed as an increase in magnitude greater than 25 % [31]. The present study showed significant increase (p < 0.05) in mean serum haptoglobin concentration (Table 1) in both treated groups and this could be interpreted as the primary action of haptoglobin to restore the homeostasis in the body [32]. Bacterial infection triggered cytokines production especially by neutrophils and macrophages which increased the rate of APPs production in general and haptoglobin in particular [33].

In ovine caseous lymphadenitis model, haptoglobin (1.65 ± 0.21 g/L) and serum amyloid A (18.1 ± 5.2 mg/L) concentrations peaked after 7 days post-injection, a point at which the acute infection became chronic [34]. Haptoglobin concentrations were the highest between day 3 and 7 post inoculation and higher between day 3, 5 and 7 post inoculation with 2x105 cfu of C. pseudotuberculosis VD57 wild strain and immunization with 250 μg CDM (chemically defined medium) antigen and 1.5 mg saponins respectively and compared to the control in sheep [35].

In the current study, mean serum haptoglobin concentration peaked up to 5 folds in the males and 3 folds in the females 14 days post-infection with C. pseudotuberculosis and up to 4 folds post-challenge with phospholipase D in both sexes (Table 1), these results were in accordance with those results reported by Abdullah et al. [31]. They observed increasing concentration of serum haptoglobin up to 7 folds in induced cases of haemorrhagic septicemia in Brangus heifers. The increased APPs concentrations may depend on the duration of the exposure to the organisms and the severity on the body tissues which in return increased the serum haptoglobin concentration in magnitude [36].

PLD inoculated goats showed almost similar pattern of response with C. pseudotuberculosis inoculated goats. This confirms the crucial role of PLD in the pathogenesis of CLA despite the absence of the microorganism, namely C. pseudotuberculosis. In fact, PLD is one of the main components of CLA commercial vaccines because of its well-known role in immune system activation and protection against C. pseudotuberculosis infection in sheep and goats [30, 37]. Eckersall et al. [34] reported increased serum haptoglobin concentration of up to 1.65 g/L within one week in induced infection of C. pseudotuberculosis in sheep. However, acute phase response was detected on day 1 post-inoculation [35]. Herein, we report that there was a significant difference in haptoglobin concentration between male and female goats. It is difficult to puzzle out such a phenomena. However, we hypothesized that males have higher blood volume, higher red blood cell count and higher haemoglobin concentration than females which may have contributed to higher Hp concentration.

Albumin is the major constituent of plasma proteins representing approximately 60 % of the entire plasma proteins, and it is considered as negative APP that shows decrease in its level upon response to infection [37], except in mastitis cases where albumin produced in the mammary gland and act as positive APP [38]. This study showed that serum albumin concentration was significantly low during week 1 to week 3 (Table 3). The cellular mechanism of positive APPs production is always associated with decrease in negative APPs particularly albumin [39]. The current study has confirmed the latter fact, with positive acute protein, particularly Hp significantly increased. Albumin has been described to decrease as a part of the metabolic response to injury or infection despite nutritional status [40].

Discordance between different APPs concentrations in illnesses and in diverse patients is common. One acute phase protein could be elevated while others may not. Such odd variations in APPs response may indicate that the acute phase reactants are individually regulated [41]. Extraordinarily, SAA showed no significant change (P > 0.05) in all treated groups (Table 2). Previous literatures showed increase in serum amyloid A concentration in a wide range of diseases in ruminants [14, 42, 43]. Echersall et al. [34] first described the SAA reaction in experimentally induced ovine CLA, but this study reported no elevation in serum amyloid A. This could be related to individual animal variation such as sex, breed, age and/or the chronic nature of CLA in goats. However, González et al. [44] reported moderate rise in Hp and no change in SAA in induced case of subacute ruminal acidosis in goats. These findings support our findings of no change of SAA post-inoculation with C. pseudotuberculosis and PLD in goats.

Conclusions

The results directly showed that Hp has the higher response to the infection with C. pseudotuberculosis and PLD challenge compared to SAA. This suggests that C. pseudotuberculosis and PLD can influence the level of APPs in goats. However, SAA was less influenced in both treated groups which may indicates that SAA in goat might be of less value upon infectious or non-infectious conditions. Nonetheless, further investigation to evaluate SAA response may be needed.

Abbreviations

CLA: 

Caseous lymphadenitis

Hp: 

Haptoglobin

SAA: 

Serum amyloid A

PLD: 

phospholipase D

C. pseudotuberculosis

Corynebacterium pseudotuberculosis

cfu: 

Colony forming unit

APPs: 

Acute phase proteins

CRP: 

C-reactive protein

CP: 

Ceruloplasmin

AGP: 

Alph 1-acid glycoprotein

IL-6: 

Interleukin-6

TNF: 

Tumor necrosis factor

IL-1-beta: 

Interleukin 1-beta

Hb: 

Haemoglobin

IACUC: 

Institutional Animal Care and Use Committee

VLSU: 

Veterinary Laboratory Service Unit

AGID: 

Agar gel immunodiffusion test

OD: 

Optic density

ELISA: 

Enzyme-linked immunosorbent assay

ANOVA: 

Analysis of variance

CDM: 

Chemically defined medium

Declarations

Acknowledgments

The authors are grateful to Mr. Yap Keng Chee, Mr. Mohd Fahmi Mashuri and Mr. Mohd Jefri Norsidin for their assistance. This work was funded by the Research University Grant Scheme (RUGS), Universiti Putra Malaysia.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Veterinary Clinical Studies, Faculty of Veterinary Medicine, UPM
(2)
Department of Clinical Studies, Faculty of Veterinary Medicine, UMK

References

  1. Komala TS, Ramlan M, Yeoh NN, Surayani AR, Sharifah Hamidah SM. A survey of caseous lymphadenitis in small ruminant farms from two districts in Perak, Malaysia-Kinta and Hilir Perak. Trop Biomed. 2008;25:196–201.PubMedGoogle Scholar
  2. Williamson LH. Caseous lymphadenitis in small ruminants. Vet Clin North Am Food Anim Pract. 2001;17(2):359–71.View ArticlePubMedGoogle Scholar
  3. Paton MW. The Epidemiology and Control of Caseous Lymphadenitis in Australian Sheep Flocks. PhD thesis. Murdoch University, 2010.Google Scholar
  4. Fontaine MC, Baird GJ. Caseous lymphadenitis. Small Ruminant Res. 2008;76(1):42–8.View ArticleGoogle Scholar
  5. Valli VEO, Parry BW. Caseous lymphadenitis. In: Jubb KVF, Kennedy PC, Palmer N, editors. Pathology of Domestic Animals. Vol. 3. 4th ed. San Diego: Academic; 1993. p. 238–40.Google Scholar
  6. Brown CC, Olander HJ. Caseous lymphadenitis of goats and sheep: a review. Vet Bull. 1987;57:1–12.Google Scholar
  7. Baird GJ, Fontaine MC. Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis. J Comp Pathol. 2007;137:179–210.View ArticlePubMedGoogle Scholar
  8. Carne HR. The toxin of Corynebacterium ovis. J Pathol Bacteriol. 1940;51:199–212. In: Baird GJ, Fontaine MC: Corynebacterium pseudotuberculosis and its role in ovine caseous lymphadenitis. J Comp Pathol. 2007;137:179-210.View ArticleGoogle Scholar
  9. Songer JG, Beckenbach K, Marshall MM, Olson GB, Kelley L. Biochemical and genetic characterization of Corynebacterium pseudotuberculosis. Am J Vet Res. 1988;49:221–6.Google Scholar
  10. Tashjian JJ, Campbell SG. Interaction between caprine macrophages and Corynebacterium pseudotuberculosis: an electron microscopic study. Am J Vet Res. 1983;44:690–3.PubMedGoogle Scholar
  11. Hard GC. Comparative toxic effect of the surface lipid of Corynebacterium ovis on peritoneal macrophages. Infect Immun. 1975;12:1439–49.PubMedPubMed CentralGoogle Scholar
  12. Titball RW. Bacterial phospholipases C. Microbiol Mol Biol R. 1993;57:347–66.Google Scholar
  13. Ceciliani F, Ceron JJ, Eckersall PD, Sauerweind H. Acute phase proteins in ruminants. J proteomics. 2012;75(14):4207–31.View ArticlePubMedGoogle Scholar
  14. Petersen HH, Nielsen JP, Heegaard PM. Application of acute phase protein measurements in veterinary clinical chemistry. Vet Res. 2004;35:163–87.View ArticlePubMedGoogle Scholar
  15. Murata H, Shimada N, Yoshioka M. Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J. 2004;168:28–40.View ArticlePubMedGoogle Scholar
  16. Yoshioka M, Watanabe A, Shimada N, Murata H, Yokomizo Y, Nakajima Y. Regulation of haptoglobin secretion by recombinant bovine cytokines in primary cultured bovine hepatocytes. Domest Anim Endocrin. 2002;23:425–33.View ArticleGoogle Scholar
  17. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621–36.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Yang F, Haile DJ, Berger FG, Herbert DC, Van Beveren E, Ghio AJ. Haptoglobin reduces lung injury associated with exposure to blood. Am J Physiol Lung Cell Mol Physiol. 2003;284:402–9.View ArticleGoogle Scholar
  19. Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, Van Kooyk Y, De Witte T, Figdor CG. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase. Blood. 2001;98:1802–11.View ArticlePubMedGoogle Scholar
  20. Schaer DJ, Roberti FS, Schoedon G, Schaffner A. Induction of the CD163-dependent haemoglobin uptake by macrophages as a novel anti-inflammatory action of glucocorticoids. Brit J Haematol. 2002;119:239–43.View ArticleGoogle Scholar
  21. El-Ghmati SM, Van Hoeyveld EM, Van Strijp JG, Ceuppens JL, Stevens EA. Identification of haptoglobin as an alternative ligand for CD11b/CD18. J Immunol. 1996;156:2542–52.PubMedGoogle Scholar
  22. Arredouani M, Matthijs P, Van Hoeyveld E, Kasran A, Baumann H, Ceuppens JL, Stevens E. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology. 2003;108:144–51.Google Scholar
  23. Xie Y, Li Y, Zhang Q, Stiller MJ, Wang CLA, Streilein JW. Haptoglobin is a natural regulator of Langerhans cell function in the skin. J Dermatol Sci. 2000;24:25–37.View ArticlePubMedGoogle Scholar
  24. Rossbacher J, Wagner L, Pasternack MS. Inhibitory effect of haptoglobin on granulocyte chemotaxis, phagocytosis and bactericidal activity. Sc J Immunol. 1999;50:399–404.View ArticleGoogle Scholar
  25. Cai L, de Beer MC, De Beer FC, van der Westhuyzen DR. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J Biol Chem. 2005;280(4):2954–61.View ArticlePubMedGoogle Scholar
  26. Gatt ME, Urieli-Shoval S, Preciado-Patt L, Fridkin M, Calco S, Azar Y, Matzner Y. Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils. J Lab Clin Med. 1998;132:414–20.Google Scholar
  27. Xu L, Badolato R, Murphy WJ, Longo DL, Anver M, Hale S, Oppenheim JJ, Wang JM. A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J Immunol. 1995;155:1184–90.Google Scholar
  28. Zaki MM. The application of a new technique for diagnosing Corynebacterium ovis infection. Res Vet Sci. 1968;9:489.PubMedGoogle Scholar
  29. Osman AY, Abdullah FFJ, Saharee AA, Haron AW, Sabri I, Abdullah R. Haematological and Biochemical Alterations in Mice Following Experimental Infection with Whole Cell and Exotoxin (PLD) Extracted from C. Pseudotuberculosis. J Anim Vet Adv. 2012;11(24):4660–7.Google Scholar
  30. Guimarães A, Carmo FB, Paulett RB, Seyffert N, Ribeiro D, Lage AP, Heinemann MB, Miyoshi M, Azevedo V, Gouveia AMG. Caseous Lymphadenitis: Epidemiology, Diagnosis, And Control. IIOAB J. 2011;2(2):33–43.Google Scholar
  31. Abdullah FFJ, Osman AY, Adamu L, Zakaria Z, Abdullah R. Acute phase protein profiles in calves following infection with whole cell, lipopolysaccharide and outer membrane protein extracted from Pasteurella multocida type B: 2. J Anim Vet Adv. 2013;8:655–62. doi:10.3923/ajava.2013.655.662.View ArticleGoogle Scholar
  32. Cray C, Zaias J, Altman NH. Acute phase response in animals: A review. Comparative Med. 2009;59:517–26.Google Scholar
  33. Ozkanlar Y, Aktas MS, Kaynar O, Ozkanlar S, Kireccl E. Bovine respiratory disease in naturally infected calves: Clinical signs, blood gases and cytokine response. Rev de Méd Vét. 2012;163:123–30.Google Scholar
  34. Eckersall PD, Lawson FP, Bence L. Acute phase protein response in an experimental model of ovine caseous lymphadenitis. BMC Vet Res. 2007;3:35–341.View ArticlePubMedPubMed CentralGoogle Scholar
  35. Bastos BL, Loureiro D, Raynal JT, Guedes MT, Vale VLC, Moura-Costa LF, Guimarães JE, Azevedo V, Portela RW, Meyer R. Association between haptoglobin and IgM levels and the clinical progression of caseous lymphadenitis in sheep. BMC Vet Res. 2013;9:254.Google Scholar
  36. Kent J. Acute phase proteins: Their use in veterinary diagnosis. Brit Vet J. 1992;148:279–82.View ArticleGoogle Scholar
  37. Fontaine MC, Baird G, Connor KM, Rudge K, Sales J, Donachie W. Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis. Vaccines. 2006;24:5986–96.View ArticleGoogle Scholar
  38. Shamay A, Homans R, Fuerman Y, Levin I, Barash H, Silanikove N. Expression of albumin in nonhepatic tissues and its synthesis by the bovine mammary gland. J Dairy Sci. 2005;88(2):569–76.View ArticlePubMedGoogle Scholar
  39. Gruys E, Obwolo MJ, Toussaint MJM. Diagnostic significance of the major acute phase proteins in veterinary clinical chemistry: a review. Vet Bull. 1994;64:1009–18.Google Scholar
  40. Dhandapani SS, Manju D, Vivekanandhan S, Sharma BS, Mahapatra AK. Prognostic value of admission serum albumin levels in patients with head injury. Pan Arab J Neurosurg. 2009;13:60–5.Google Scholar
  41. Samols D, Agrawal A, Kushner I. Acute phase proteins. Cytokine reference on-line. 2009.Google Scholar
  42. Eckersall PD, Bell R. Acute phase proteins: biomarkers of infection and inflammation in veterinary medicine. Vet J. 2010;185:23–7.View ArticlePubMedGoogle Scholar
  43. Heegaard PM, Godson DL, Toussaint MJ, Tjornehoj K, Larsen LE, Viuff B, Ronsholt L. The acute phase response of haptoglobin and serum amyloid A (SAA) in cattle undergoing experimental infection with bovine respiratory syncytial virus. Vet Immunol Immunop. 2000;77:151–9.Google Scholar
  44. González FHD, Ruiperez FH, Sanches JM, Sanza JC, Marinez-subield S. Haptoglobin and serum amyloid A in subacute ruminal acidosis in goats. Rev Med Vet Zoot. 2010;57:3.Google Scholar

Copyright

© Jeber et al. 2016